Skip to content
OpenCapital
Get started

Sana Biotechnology SANA Q4 2025 Annual earnings

Reported March 3, 2026 · After market close

EPS-$0.16Miss by $0.03
EPS estimate-$0.13

Next report

Aug 10, 2026 (In 1 week)
EPS estimate-$0.15

Financials

Q4 2025

Income statement

See full
Operating income-$61.2M-20.3%
Net income-$58.8M-19.9%
EPS (diluted)-$0.210.0%

Balance sheet

See full
Cash & equivalents$71.9M-43.7%
Total debt$78.9M-16.3%
Total equity$160.9M-35.8%
Total assets$416.9M-16.8%

Cash flow

See full
Operating cash flow-$32.6M+30.8%
CapEx$873.0K+100%
Free cash flow-$33.5M+29.6%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.08B+198%
Enterprise value$1.09B+230%

Returns & leverage

See full
Return on equity-118.7%+29.1pp
Debt / equity0.5×+0.1×
Current ratio1.9×-1.7×

Versus estimates

Diluted EPS

Q1 2026-$0.14Beat by $0.01
Q4 2025-$0.16Miss by $0.03
Q3 2025-$0.15Beat by $0.03Q2 2025-$0.16Beat by $0.04Q1 2025-$0.20Beat by $0.02Q4 2024-$0.23Beat by $0.02

Ask the moment Sana Biotechnology reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Sana Biotechnology report Q4 2025 earnings?
Sana Biotechnology (SANA) reported Q4 2025 earnings on March 3, 2026 after market close.
What were Sana Biotechnology's Q4 2025 revenue and EPS?
Sana Biotechnology reported eps of $-0.16 for Q4 2025.
Did Sana Biotechnology beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.13 by $0.03.
How did Sana Biotechnology's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 30.4% from $-0.23.
Where can I find Sana Biotechnology's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-088203) and the 10-K periodic report (0001193125-26-088215) directly on SEC EDGAR. The filing index links above go to sec.gov.